Ally Bridge Group »

Enliven Therapeutics shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2025-06-30 $5.6M 281k 20.06
2025-03-31 $3.3M 170k 19.68
2024-12-31 $3.2M 142k 22.50
2024-09-30 $6.0M 235k 25.54